Bank of New York Mellon’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.2M | Buy |
496,061
+249,331
| +101% | +$12.7M | ﹤0.01% | 1395 |
|
|
2025
Q1 | $11.1M | Buy |
246,730
+122,402
| +98% | +$5.51M | ﹤0.01% | 1798 |
|
|
2024
Q4 | $5.14M | Buy |
124,328
+9,629
| +8% | +$398K | ﹤0.01% | 2267 |
|
|
2024
Q3 | $4.47M | Sell |
114,699
-28,301
| -20% | -$1.1M | ﹤0.01% | 2344 |
|
|
2024
Q2 | $4.89M | Buy |
143,000
+46,506
| +48% | +$1.59M | ﹤0.01% | 2356 |
|
|
2024
Q1 | $2.42M | Sell |
96,494
-20,790
| -18% | -$522K | ﹤0.01% | 2664 |
|
|
2023
Q4 | $3.46M | Sell |
117,284
-767
| -0.6% | -$22.6K | ﹤0.01% | 2554 |
|
|
2023
Q3 | $3.73M | Buy |
118,051
+5,861
| +5% | +$185K | ﹤0.01% | 2469 |
|
|
2023
Q2 | $2.9M | Buy |
112,190
+52,333
| +87% | +$1.35M | ﹤0.01% | 2626 |
|
|
2023
Q1 | $1.44M | Sell |
59,857
-5,655
| -9% | -$136K | ﹤0.01% | 2974 |
|
|
2022
Q4 | $1.28M | Buy |
65,512
+4,737
| +8% | +$92.4K | ﹤0.01% | 3077 |
|
|
2022
Q3 | $1.28M | Sell |
60,775
-12,872
| -17% | -$270K | ﹤0.01% | 3089 |
|
|
2022
Q2 | $1.43M | Buy |
73,647
+50,279
| +215% | +$978K | ﹤0.01% | 3018 |
|
|
2022
Q1 | $515K | Sell |
23,368
-826
| -3% | -$18.2K | ﹤0.01% | 3684 |
|
|
2021
Q4 | $385K | Buy |
24,194
+350
| +1% | +$5.57K | ﹤0.01% | 3952 |
|
|
2021
Q3 | $475K | Buy |
23,844
+416
| +2% | +$8.29K | ﹤0.01% | 3834 |
|
|
2021
Q2 | $405K | Sell |
23,428
-3,479
| -13% | -$60.1K | ﹤0.01% | 3860 |
|
|
2021
Q1 | $534K | Sell |
26,907
-663
| -2% | -$13.2K | ﹤0.01% | 3653 |
|
|
2020
Q4 | $481K | Buy |
27,570
+8,142
| +42% | +$142K | ﹤0.01% | 3632 |
|
|
2020
Q3 | $374K | Sell |
19,428
-575
| -3% | -$11.1K | ﹤0.01% | 3625 |
|
|
2020
Q2 | $389K | Buy |
20,003
+2,875
| +17% | +$55.9K | ﹤0.01% | 3592 |
|
|
2020
Q1 | $240K | Buy |
17,128
+5,620
| +49% | +$78.7K | ﹤0.01% | 3680 |
|
|
2019
Q4 | $282K | Buy |
+11,508
| New | +$282K | ﹤0.01% | 3822 |
|